Inschrijving geopend voor nieuw platform zorg en welzijn Gelderland-midden!

Samen Kwiek: een gebruiksvriendelijk, duurzaam en regionaal digitaal dienstenplatform voor zorg en welzijn. Het doel is om zorg en welzijn in Gelderland-Midden dichterbij te brengen en zo de levenskwaliteit van inwoners te verbeteren. De Gemeente Lingewaard, Stichting Welzijn Lingewaard, Rijnstate en Health bouwen het platform vanuit het Europese project dRural. Nu komt het moment waarop nog meer partijen mee kunnen doen en mee kunnen werken. Partijen die geselecteerd worden om mee te werken aan het platform ontvangen hiervoor een subsidie van € 5.000,- of € 50.000,- (afhankelijk van de bijdrage aan het platform). Inschrijven kan tot 15 januari 2023 via: https://samenkwiek.nu/page/meedoen/

Met het nieuw te bouwen platform, zorgen we voor betere zichtbaarheid en samenwerking tussen de nulde lijn (waaronder sociaal domein en welzijn), eerste lijn (waaronder huisartsen en fysiotherapeuten), en tweede lijn (zoals het ziekenhuis). Door laagdrempelig in te zetten op preventie, voelen mensen zich gezonder en fijner en voorkomen we dure (ziekenhuis)zorg.

Bouw mee!

Schrijf u in vóór 15 januari 2023. Partijen die geselecteerd worden om mee te werken aan het platform ontvangen hiervoor een subsidie van € 5.000,- (deelnemers) of € 50.000,- (mede-ontwikkelaars). Wij zoeken verschillende partners die samen met ons het platform willen ontwikkelen, hun diensten willen aanbieden of zorgsystemen of andere applicaties willen integreren. We zoeken specifiek naar deze organisaties:

Zorgpartijen:

  • Nulde lijn: sociaal domein & welzijnsorganisaties, wandelgroepen, aanbieders van beweegactiviteiten
  • Eerste lijn: zorgpartijen, bijvoorbeeld huisartsen, psychologen, fysiotherapeuten, logopedisten, thuiszorg, diëtisten, podotherapeuten
  • Tweede lijn: zorgorganisaties, bijvoorbeeld ziekenhuizen

Bedrijven met zorgoplossingen, bijvoorbeeld:

  • Organisaties die data/informatie genereren of verwerken in het sociaal en zorgdomein of informatie toevoegen aan het platform
  • PGO-bedrijven die patiëntgegevens beheren.
  • Applicaties die gebruikt worden door patiënten in het domein gezondheid/welzijn (voeding, slaap, activiteit, enz.)
  • Applicaties die communicatie en zorgsamenwerking tussen professionals en patiënten mogelijk maken.
  • Softwaretools die door professionals worden gebruikt om hun praktijken, afdelingen, workflows te beheren (bijvoorbeeld EPD’s, planningstools en CRM’s).

Meer informatie?

Kijk op https://samenkwiek.nu/page/meedoen/ of mail naar info@samenkwiek.nu. 

Inschrijven nieuwsbrief

Op de hoogte blijven van het laatste nieuws? Schrijf in voor de nieuwsbrief van Samen Kwiek.

Successful matchmaking at Radboudumc Investment Day

On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day. The event, jointly hosted by Radboudumc, Oost NL and Briskr, aims to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.

This years’ edition featured an inspiring line-up of speakers with broad expertise in (bio)medical innovation, med tech and AI. Together, they touched upon the main challenges and opportunities that scientists and entrepreneurs face when they try to bring their research to the market. One key takeaway was the importance for scientist and (potential) investors to get in touch early on in the research process. That makes it easier to align applied research with societal needs and lowers the chance of promising start-ups folding in the infamous ‘valley of death’.

In addition to the plenary sessions, attendees had ample opportunity to partake in one-on-one meetings, some of which were pre-arranged via a digital match-up platform.

The spirit of the event was aptly summarized by Constantijn van Oranje, special envoy at TechLeap, during the panel discussion at the end. He emphasized the importance of creating a culture at academic institutions that actively supports and even celebrates entrepreneurial scientists. For while the academic pursuit of knowledge is a valuable endeavor in itself, translating the fruits of research into market success and societal impact is equally important and that’s why we will organize the event next year as well.

Lifeport Welcome Center officially opens its doors to international knowledge workers and students

International knowledge workers and students, as well as their employers and knowledge institutions, now have a one-stop shop on the Radboud University campus for any matters related to making their stay in the region more pleasant. The Lifeport Welcome Centre at Huize Heyendael was officially opened on 19 September.

The Lifeport Welcome Center (LWC) is staffed by Radboud University employees.  In October, they will be joined at the Huize Heyendael location by employees from the municipality of Nijmegen, and from 1 January 2023 onwards, by colleagues from the Immigration and Naturalisation Service (Immigratie- en Naturalisatiedienst, IND). From then onwards, the municipality of Nijmegen and IND will join forces to offer a one-stop shop of governmental services related to registration and residence.

Expanding services over time

The Lifeport Welcome Center is a single central point where international knowledge workers, students, their employers and family members can go for government services (offered by the municipality and IND), private services (such as a welcome programme and “family support” programme), and social activities. They will receive a welcome package, and information on matters such as health insurance, banking, and filing income tax returns in the Netherlands.

In time, these services can be expanded to include support in finding housing, and various training courses. The Lifeport Welcome Center will initially run for a period of two years, following which an evaluation will take place.

Wijnand Hemelaar, Director of Lifeport Welcome Center and coordinator of the Radboud University Global Staff Services: “This is a new initiative in the Arnhem-Nijmegen region. We expect it to make an important contribution towards attracting and retaining international talent in the region.”

Regional initiative

Lifeport Welcome Center is an initiative of the Economic Board, the province of Gelderland, and the municipality of Nijmegen, based on the regional desire to attract and retain more international talent for the region. The project is financed by Radboud University, the Province of Gelderland, the HAN University of Applied Sciences, the Economic Board, and a number of private parties that offer services at a fee (banks, insurers, brokers, etc.). Companies and institutions in the region can also make use of the Welcome Center’s services at a fee. Daniël Wigboldus, President of the Executive Board of Radboud University and member of the Economic Board: “At the Radboud campus, we find it important to join forces with the municipality of Nijmegen, the province, IND, the HAN University of Applied Sciences, and all other Lifeport partners to attract the necessary international talent to the region and keep them here.”

In addition to the Lifeport Welcome Center @Radboud University, other locations for welcoming international talent may be opened in the Nijmegen-Arnhem-Wageningen region in future. The Lifeport Welcome Center is also working in close collaboration with the Welcome Center Food Valley in Wageningen to share knowledge and develop joint programmes, thus serving the entire region.

Contact information

Learn more about the Lifeport Welcome Center at www.thelifenet.eu
You can reach the Lifeport Welcome Center at info@lifeportwelcomecenter.nl

IDEE ZOEKT ONDERNEMER

Word je eigen BAAS! Win een eigen onderneming en €15.000 aan prijzen.

Vrijheid, onafhankelijkheid en doen wat je leuk vindt en waar je passie ligt. Dat zijn voor veel startende ondernemers de drijfveren om een eigen bedrijf op te starten. Voor jongeren die willen starten met ondernemen, is het soms lastig om te bedenken wat voor onderneming je wilt starten. Daar biedt Word je eigen BAAS! van StartUp Nijmegen, aanjagers Dick Bos en Jan van Raaij,  een oplossing voor. 

DE WERELD OP ZIJN KOP!

Bij ZomerOndernemer staan de ondernemers en zijn/haar idee centraal. Nu staat het idee centraal en zoeken we een ondernemer die hierbij past en die krijgt een vliegende start in coaching en geld ter waarde van pakweg €15.000,-.

Spreekt een van deze ideeën je aan? Lees dan snel verder!

1 My Pop-Up Kitchen, als ondernemer faciliteer je een locatie voor koks die de restaurantwereld
   een tijdje willen uitproberen.

2 Dream Job, een app die onderweg actuele en voor jou interessante vacatures zoekt.

3 Medimee, een reisetui om jouw medicijnen veilig en geordend overal mee naartoe te nemen.

4 The Climate Changers, een platform waar woningbezitters met behulp van vakmensen hun huis
   kunnen verduurzamen én uiteindelijk andere mensen kunnen helpen.

Het concept

Tijdens ‘Word je eigen BAAS!’ worden vier businessideeën weggegeven, zie hierboven. Als deelnemer krijg je de mogelijk-heid om vier minuten te pitchen voor een vakkundige jury die bestaat uit wethouder John Brom (EZ), Simon de Luij (Modder-kolk), Chantal Peters (De Papierfabriek), en Martine Grol (Made by Media).

Prijzenpakket

Om de winnaars van Word je eigen BAAS! een vliegende start mee te geven is een prijzenpakket samengesteld ter waarde van €15.000,-. Dit pakket ziet er als volgt uit:

– €2.500,- van de Gemeente Nijmegen
– 6 maanden werkplek en begeleiding bij StartUp Nijmegen
– Je eigen businesscoach (Roeland Bridié; Lizanne Jacobs; Cees van Diemen of Ton Foks)
– Je 1e jaarrekening wordt gratis opgesteld
– Refurbished laptop
– Merkstrategie en branding training
– Website
– SEO-pakket
– Workshop (web)tekst schrijven
– Bedrijfsprofiel en persbericht in MT/Sprout
– Customer Experience Kickstart

– Managementboeken

Deelnemen aan Word je eigen BAAS!?

Voor Word je eigen BAAS! is StartUp Nijmegen op zoek naar toekomstige zelfstandige ondernemers die op één van de vier businessideeën willen pitchen. De voorwaarden om deel te nemen: je gaat bij StartUp Nijmegen starten, vestigt jouw bedrijf in Nijmegen én je hebt geen andere onderneming waarvoor je verantwoordelijkheden hebt.

Aanmelden kan via: tessa@startupnijmegen.nl met contactge-gevens, motivatiebrief en CV. Zorg dat jouw inschrijving vóór 1 oktober 24.00 uur binnen is. Uiterlijk 6 oktober krijg je bevestiging van deelname. 

Word je eigen BAAS! vindt plaats op 13 oktober in de Raadzaal van de Gemeente Nijmegen, Korte Nieuwstraat 6, 6511 PP Nijmegen, van 15.00 uur tot 18.00 uur.  Op de website van StartUp Nijmegen vind je meer informatie over de wedstrijd, voorwaarden en het volledige prijzenpakket.

Fighting stigma with technology and connections

Novioscan makes a positive impact with its solution for one of the biggest hidden problems the world is facing: incontinence. Their story is a great example of a bright idea turning into a reality by finding skilled people to believe in your vision.

The basic idea of Novioscan’s invention is simple: avoid wet accidents by notifying the child or patient that they have to go to the bathroom or get help. Rob Tweehuysen, one of Novioscan’s co-founders, explains: “We noticed a great need for a solution like ours. We started with the objective to help young children, who don’t want to wear a diaper at school. But we learned that incontinence is a bigger societal problem, so we are working on solutions for older generations as well”, he says.

Briskr was right across the street
Novioscan started with an idea, which quickly became a real-life solution. Their location in Nijmegen, with loads of supply in terms of knowledge and chip industry, surely helped. Finding your way in that maze of possible connections is not always easy, says Rob. “Right across the street was Briskr. We needed a networking organization like them to be able to connect to others like HealthValley, OostNL, and the University. It’s an ongoing process, but it sure is nice to have a guide.”Diligent, but accurate
Novioscan’s technology works through ultrasound. A small device is placed on the abdomen, right where the bladder is. It sends sound signals inwards to receive an echo. Based on the time it takes for that echo to reach the device, it can precisely measure the amount of urine in the bladder. An invention that has changed lives, says Rob. “The problem is largely hidden, one in fifteen children has a problem with continence.”

The potential impact is not restricted to young children, as incontinence is a problem that older generations are facing as well. Novioscan is currently working on the ‘adult version’ of their product. “We are working on pilots with adults. The device needs to have the ability to measure at more points due to the various shapes of bladder that adults have, but we are confident that we’ll be able to apply our proprietary technology. Eventually, the goal is to make the product even smaller and therefore more diligent”, says Rob.

Managing continence instead of treating incontinence
Turning innovation into an actual product takes more than just a good idea. In their search for investors, Novioscan found worldwide hygiene and health company Essity, quickly after they started their mission. Axel Nordberg is a global director for digital solutions at Essity, who is the owning partner of Novioscan. He is very excited to be involved in developing Novioscan’s product. “There are 400 million people in the world with incontinence, but the problem is often underestimated, due to stigma.” Essity is one of the biggest global companies in absorbent products with a clear agenda in digital solutions. They invest in good ideas to improve the quality of life. “We develop a lot of products ourselves, and Novioscan’s solution ticked many of the boxes we look for. It comes down to this: we want to support our customers and consumers to manage continence instead of thinking about treating incontinence”, says Axel.

For a relatively young company like Novioscan, Essity proved an ideal partner, says Rob. “Thanks to Essity, we could actually take the product to the market.” Axel adds that this is very important to further develop the product to fine-tune the product. “Feedback from users gives us information about our user’s needs. People stay at home in fear of leakage, compromising their freedom. We want to hear how they are best helped by applying technology.”

New spin-off QurieGen can have a major impact on drug development

QurieGen is a new spin-off of Radboud University that supports pharmaceutical companies in the early identification of successful drug molecules. This will have a major impact on the drug development process as it will enable rapid decision-making during drug design cycles to determine successful drug candidates for further studies on patients and drug combinations studies.

QurieGen has developed a unique method (QuRIEseq) to quantitatively map the mode of action of drug candidates across multiple pathways. The platform allows for high-throughput simultaneous quantification of multiple molecular “layers”: mRNA molecules and 100’ (potentially 1000’) membrane and intracellular (phospho)proteins across multiple pathways with single-cell resolution. This innovation replaces many different, mutually incompatible analytical tools that at best provide an incomplete picture of the cell response to drug perturbations.

Kinga Matula, a postdoc at Radboud University and co-founder and CEO of QurieGen: “Many drugs are designed to block a certain single target or protein in a signaling pathway. But our linear view of these pathways belies the enormous complexity of cellular networks. There is a severe lack of quantitative understanding of the mode of action of drug molecules across multiple pathways. We need tools that will allow us to capture and ‘untangle’ the full complexity of signaling networks and obtain the quantitative map of the dynamics of the cellular response. This will help to understand how drug candidates work before they enter preclinical testing and clinical trials, preventing the occurrence of unexpected downstream effects that are leading to diminished efficacy, toxic side effects, or the origin of resistance. Such a solution will be a ‘game changer’ – it will save time and  money but also open the route to design new (better) treatment for patients.”

Major impact on drug development

QurieGen’s new and unique method will have a major impact on the drug development process as it provides insight into patient response to drugs, identifies promising drug targets, and opens up new routes for studying (new and more effective) drug combinations, or finding new disease patterns.

The near-term business goal is to build QurieGenQurieGen’s reputation as a leader in the field and engage with pharma R&D to identify the most suitable pathways and disease areas.

QurieGens’ long term goal is to enable the data-driven discovery of new cellular response patterns and new drug targets. By quantifying the cellular response to hundreds of cancer drugs and stimuli, they will generate a large data sets necessary to train algorithms that can identify cell-type- or patient-specific responses to drugs, and new drug targets. QurieGen is now taking the first steps towards the algorithm-driven approach by studying the mode of action of four BTK-inhibitors used for B-cell cancer treatment.

The potential of the QurieGen technology is appreciated by key players in the field, as evidenced by pilot trials with Aduro Biotech (Oss, the Netherlands), Janssen Pharmaceutica J&J (Beerse, Belgium), and Acerta Pharma (part of AstraZeneca, Oss, the Netherlands).

In may 2022, QurieGen won the NWO Venture Challenge.

World-leading scientists

The core of the QurieGen team is composed of entrepreneurs and scientists with strong expertise in single-cell, pharma, and business development. The technology development is based on years of experience and access to state-of-the-art equipment and know-how.

The founding team consists of:

  • Dr. eng. Kinga Matuła (CEO), co-founder, In 2018, she was working as a postdoctoral researcher in a spin-off company Cytofind Diagnostics, Dr. Matuła is a recipient of the Primus inter pares award (for best graduates of Rzeszow University, Poland), Young researchers Institute of Physical Chemistry PAS’ award (2017), and  5 grants. Dr. Matuła has extensive experience in single-cell multi-omics, microfluidics, cancer biology, and chemical and process engineering
  • Prof. dr. Wilhelm Huck, board member, co-founder and Chair of the Scientific Advisory Board of Sphere Fluidics (2010), co-founder of Cytofind Diagnostics (2017) and QurieGen (2022). Spinoza prize winner (2016)  , Groeifonds winner (2022)
  • Dr. Hans van Eenennaam, Scientific and business advisor. Has over 20 years of experience in pharma R&D, was co-founder of BioNovion, co-inventor of Keytruda and former executive VP of Aduro Biotech Europe. Dr. Hans Eenennaam, recently served as Chief Scientific Officer of AIMM Therapeutics and up until March 2019 as Executive Vice President of Antibody Research and Site Head for Aduro Biotech Europe.
  • Ir. Jasper Levink, a former Board Member & Managing Director of Ttopstart, which transforms healthcare and life sciences by accelerating the introduction of impactful innovations, he is Non-Executive Board Member & Co-Owner of  doccs | de slimme aanpak voor betere zorg and co-Founder and Chairman of the Supervisory Board of Feniks and is CBO at LenioBio GmbH

Website EFRO grant period 2021-2027

For the EFRO program period 2021-2027, the new website www.efro-oost.eu was recently put online. On this site, you can find all the current information about the program EFRO 2021-2027 for Eastern Netherlands.

In the coming period, the site will be further supplemented with information about the grant opportunities, openings, rules, budgets, news, stories from entrepreneurs/beneficiaries and information needed for progress and final reports. Keep an eye on this website if you are an entrepreneur and would like to make use of it. (Please note, the website is in Dutch)

Zomer Ondernemer Rijk van Nijmegen

The ZomerOndernemer Rijk van Nijmegen project will start in mid-July. ZomerOndernemer Rijk van Nijmegen is an entrepreneurial project in which young people aged between 15 and 25 living in the region are helped to start up their own business. In this way, young people can become acquainted with entrepreneurship. An entrepreneurial attitude offers more perspective. You see more opportunities and possibilities and that is exactly what is transferred and stimulated among this target group.

The participants receive professional coaching and resources not only to work out the business idea, but also to execute the idea. In the past, this has resulted in numerous young people starting their own businesses thanks to ZomerOndernemer. And that throughout the Netherlands.

This project is being carried out in collaboration with various companies in the Nijmegen region. This includes workshops, speakers and company visits to interesting entrepreneurs. The project lasts 6 weeks with a three-day entrepreneurial training as a kick-off. This is followed by a number of return days followed by a festive kick-off where the participants present their own company.

Participation is completely free and is made possible by Fonds 21 and the municipalities of Nijmegen, Beuningen, Wijchen, Berg en Dal and Druten. More information: www.zomerondernemer.nl.

Press release: MS Sherpa receives an investment of 1.5 million euros

MS Sherpa, a medical device that monitors the course of symptoms of MS, will receive an investment of 1.5 million euros. In recent years, the Nijmegen data science company Orikami has developed MS Sherpa as a medical product, clinically validated it and CE certified.

With the new capital, Sherpa BV will now continue independently as a start-up to grow in the Netherlands and Germany, but also to develop a new product and apply it in Parkinson’s disease.
With MS Sherpa , people with MS and medical specialists gain insight into the presence and progression of MS symptoms by regularly performing self-tests on their smartphones. With the help of digital biomarkers, personalized information becomes available, which is used to monitor the disease course and the effect of the treatment and to make adjustments where necessary.
With the investment, the company will continue to build on the product in the coming years and make the solution available to medical specialists and people with MS in the Netherlands and internationally. The app is already available in the app store and can be used by someone with MS on prescription from the neurologist.
With the available knowledge about digital biomarkers and neurological diseases, work is also being done on an application in Parkinson’s disease, says the new CEO Jacco Schutte. “With digital biomarkers, we can gain increasingly easier and better insight into the course of complex neurological disorders. In this way we make a positive contribution to treatment and efficient affordable care”.

Read more.

Get a weekly pitch tip from Frank Smallegange

To keep your public speaking skills fresh you should work on them on a regular basis. For most of us however the trigger to work on these skills is when we have to give our next presentation. To make it easy to keep your presentation skills on top of mind he started #FrankSays. With this hashtag he publishes, every Thursday, a practical pitch tip on Linked In.

If you want to keep improving your public speaking skills follow him on Linked In.